Login / Signup

AcrIF5 specifically targets DNA-bound CRISPR-Cas surveillance complex for inhibition.

Yongchao XieLaixing ZhangZhengyu GaoPeipei YinHao WangHang LiZeliang ChenYi ZhangMaojun YangYue Feng
Published in: Nature chemical biology (2022)
CRISPR-Cas systems are prokaryotic antiviral systems, and phages use anti-CRISPR proteins (Acrs) to inactivate these systems. Here we present structural and functional analyses of AcrIF5, exploring its unique anti-CRISPR mechanism. AcrIF5 shows binding specificity only for the target DNA-bound form of the crRNA-guided surveillance (Csy) complex, but not the apo Csy complex from the type I-F CRISPR-Cas system. We solved the structure of the Csy-dsDNA-AcrIF5 complex, revealing that the conformational changes of the Csy complex caused by dsDNA binding dictate the binding specificity for the Csy-dsDNA complex by AcrIF5. Mechanistically, five AcrIF5 molecules bind one Csy-dsDNA complex, which destabilizes the helical bundle domain of Cas8f, thus preventing subsequent Cas2/3 recruitment. AcrIF5 exists in symbiosis with AcrIF3, which blocks Cas2/3 recruitment. This attack on the recruitment event stands in contrast to the conventional mechanisms of blocking binding of target DNA. Overall, our study reveals an unprecedented mechanism of CRISPR-Cas inhibition by AcrIF5.
Keyphrases
  • crispr cas
  • genome editing
  • public health
  • single molecule
  • circulating tumor
  • magnetic resonance
  • cell free
  • dna binding
  • magnetic resonance imaging
  • molecular dynamics
  • dna methylation
  • transcription factor